E23.7: Disorder of pituitary gland, unspecified
E23.7, disorder of pituitary gland, unspecified, is listed as a covered diagnosis in 3 Medicare billing and coding articles that apply to 14 HCPCS Level II codes, including J1071 (Injection, testosterone cypionate, 1 mg), J3145 (Injection, testosterone undecanoate, 1 mg), J3490 (Unclassified drugs). The articles come from 2 Medicare contractors. A listed diagnosis supports medical necessity only; coverage still depends on the LCD's criteria and on documentation in the medical record.
HCPCS Level II codes with E23.7 as a covered diagnosis
| Code | Description | Medicare coverage | DMEPOS fee 2026 (state range) | Articles listing it |
|---|---|---|---|---|
| J1071 | Injection, testosterone cypionate, 1 mg | Special coverage instructions apply | — | 2 |
| J3145 | Injection, testosterone undecanoate, 1 mg | Special coverage instructions apply | — | 2 |
| J3490 | Unclassified drugs | Special coverage instructions apply | — | 2 |
| J3121 | Injection, testosterone enanthate, 1 mg | Special coverage instructions apply | — | 2 |
| J1072 | Injection, testosterone cypionate (azmiro), 1 mg | Special coverage instructions apply | — | 1 |
| G2187 | Patients with clinical indications for imaging of the head: head trauma | Carrier judgment | — | 1 |
| G2188 | Patients with clinical indications for imaging of the head: new or change in headache above 50 years of age | Carrier judgment | — | 1 |
| G2189 | Patients with clinical indications for imaging of the head: abnormal neurologic exam | Carrier judgment | — | 1 |
| G2190 | Patients with clinical indications for imaging of the head: headache radiating to the neck | Carrier judgment | — | 1 |
| G2191 | Patients with clinical indications for imaging of the head: positional headaches | Carrier judgment | — | 1 |
| G2192 | Patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age | Carrier judgment | — | 1 |
| G2193 | Patients with clinical indications for imaging of the head: new onset headache in pre-school children or younger (<6 years of age) | Carrier judgment | — | 1 |
| G2194 | Patients with clinical indications for imaging of the head: new onset headache in pediatric patients with disabilities for which headache is a concern as inferred from behavior | Carrier judgment | — | 1 |
| G2195 | Patients with clinical indications for imaging of the head: occipital headache in children | Carrier judgment | — | 1 |
Medicare policy articles listing E23.7
- A57615: Billing and Coding: Treatment of Males with Low Testosterone (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B); 4 Level II codes). LCD with the same title: L36538, L39086
- A58828: Billing and Coding: Treatment of Males with Low Testosterone (Palmetto GBA (MAC - Part A, MAC - Part B); 5 Level II codes). LCD with the same title: L36538, L39086
- A56612: Billing and Coding: CT of the Head (Palmetto GBA (MAC - Part A, MAC - Part B); 9 Level II codes). LCD with the same title: L34417
A diagnosis listed as covered in a billing and coding article supports medical necessity for the article's codes; it does not guarantee payment. Coverage depends on the LCD's criteria, the contractor's jurisdiction and documentation in the medical record.
Other E23 diagnoses (Hypofunction and other disorders of the pituitary gland)
- E23.0 — Hypopituitarism
- E23.1 — Drug-induced hypopituitarism
- E23.3 — Hypothalamic dysfunction, not elsewhere classified
- E23.6 — Other disorders of pituitary gland
Frequently asked questions
Does Medicare cover E23.7 (Disorder of pituitary gland, unspecified)?
Medicare covers items and services, not diagnoses. 3 Medicare billing and coding articles list E23.7 as a covered diagnosis for 14 HCPCS Level II codes: the diagnosis can support medical necessity for those codes, but payment still depends on the LCD's coverage criteria and the medical record.
Which HCPCS codes can be billed with ICD-10 E23.7?
The Level II codes from the policies most specific to this diagnosis are J1071 (Injection, testosterone cypionate, 1 mg, 2 articles); J3145 (Injection, testosterone undecanoate, 1 mg, 2 articles); J3490 (Unclassified drugs, 2 articles); J3121 (Injection, testosterone enanthate, 1 mg, 2 articles); J1072 (Injection, testosterone cypionate (azmiro), 1 mg, 1 article). Code choice depends on the item supplied; check each code's descriptor.
Which Medicare policy articles list E23.7?
A57615 (Billing and Coding: Treatment of Males with Low Testosterone); A58828 (Billing and Coding: Treatment of Males with Low Testosterone); A56612 (Billing and Coding: CT of the Head).
What is ICD-10-CM code E23.7?
E23.7 is the ICD-10-CM code for disorder of pituitary gland, unspecified, in category E23 (Hypofunction and other disorders of the pituitary gland), chapter 4: Endocrine, nutritional and metabolic diseases.
Next steps
- Run a reimbursement report for a device billed under J1071
- Watch J1071 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1071
Sources: CMS Medicare Coverage Database billing and coding articles (covered ICD-10 code lists and HCPCS links); ICD-10-CM FY2026; CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule 2026 (non-rural state fees). Not billing or legal advice.
Chapter 4: Endocrine, nutritional and metabolic diseases · All diagnoses · HCPCS lookup